Ghent University Academic Bibliography

Advanced

Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis

Martine De Vos UGent, J Jahnsen, J Vandervoort, G D'haens, O Dewit, E Louis, D Franchimont, F Baert, R Torp and P Potvin, et al. (2012) JOURNAL OF CROHNS & COLITIS. 6(suppl. 1). p.S4-S4
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
JOURNAL OF CROHNS & COLITIS
J. Crohn. Colitis
volume
6
issue
suppl. 1
article_number
abstract OP07
pages
S4 - S4
conference name
7th Congress of ECCO
conference location
Barcelona, Spain
conference start
2102-02-16
conference end
2012-02-18
ISSN
1873-9954
DOI
10.1016/S1873-9946(12)60008-7
language
English
UGent publication?
yes
classification
C3
copyright statement
I have transferred the copyright for this publication to the publisher
id
2047668
handle
http://hdl.handle.net/1854/LU-2047668
date created
2012-02-27 16:14:30
date last changed
2013-02-26 11:09:30
@inproceedings{2047668,
  articleno    = {abstract OP07},
  author       = {De Vos, Martine and Jahnsen, J and Vandervoort, J and D'haens, G and Dewit, O and Louis, E and Franchimont, D and Baert, F and Torp, R and Potvin, P and Van Hootegem, P and Henriksen, M and VANDER CRUYSSEN, BERT and Vermeire, S},
  booktitle    = {JOURNAL OF CROHNS \& COLITIS},
  issn         = {1873-9954},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 1},
  pages        = {abstract OP07:S4--abstract OP07:S4},
  title        = {Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis},
  url          = {http://dx.doi.org/10.1016/S1873-9946(12)60008-7},
  volume       = {6},
  year         = {2012},
}

Chicago
De Vos, Martine, J Jahnsen, J Vandervoort, G D’haens, O Dewit, E Louis, D Franchimont, et al. 2012. “Use of Fecal Calprotectin as Marker of Disease Activity in Patients Under Maintenance Treatment with Infliximab for Ulcerative Colitis.” In Journal of Crohns & Colitis, 6:S4–S4.
APA
De Vos, Martine, Jahnsen, J., Vandervoort, J., D’haens, G., Dewit, O., Louis, E., Franchimont, D., et al. (2012). Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis. JOURNAL OF CROHNS & COLITIS (Vol. 6, pp. S4–S4). Presented at the 7th Congress of ECCO.
Vancouver
1.
De Vos M, Jahnsen J, Vandervoort J, D’haens G, Dewit O, Louis E, et al. Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis. JOURNAL OF CROHNS & COLITIS. 2012. p. S4–S4.
MLA
De Vos, Martine, J Jahnsen, J Vandervoort, et al. “Use of Fecal Calprotectin as Marker of Disease Activity in Patients Under Maintenance Treatment with Infliximab for Ulcerative Colitis.” Journal of Crohns & Colitis. Vol. 6. 2012. S4–S4. Print.